General Motors is set to report earnings before the bell

General Motors is set to report earnings before the bell


A GMC pickup truck is displayed for sale on a lot at a General Motors dealership in Austin, Texas, on Jan. 5, 2023.

Brandon Bell | Getty Images

DETROIT — General Motors is set to report second-quarter results before the bell Tuesday.

Wall Street expects GM to be the standout among the traditional Detroit automakers, with sales and vehicle prices stable during the first half of the year for America’s largest carmaker.

Here is what analysts expect, according to average estimates compiled by LSEG:

  • Earnings per share: $2.75 adjusted
  • Revenue: $45.46 billion

Those results would mark a 1.6% increase in revenue compared to a year earlier and a 44.2% increase in adjusted earnings per share. GM’s second-quarter results last year included $44.75 billion in revenue, net income attributable to stockholders of $2.57 billion and adjusted earnings before interest and taxes of $3.23 billion.

Several Wall Street analysts expect GM to guide toward the higher end of the automaker’s already raised guidance for 2024, if not hike it again.

GM’s 2024 guidance includes adjusted earnings of $12.5 billion to $14.5 billion, or $9 to $10 a share, and adjusted automotive free cash flow in a range of $8.5 billion to $10.5 billion.

Other than second-quarter results and 2024 guidance, investors will be watching for updates regarding the automaker’s all-electric vehicle plans, capital spend and operations in China, where GM has recently faced issues with sales and earnings.

This is developing news. Please check back for additional updates.



Source

Moderna says FDA refuses to review its application for experimental flu shot
Business

Moderna says FDA refuses to review its application for experimental flu shot

A researcher works in the lab at the Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024. Adam Glanzman | Bloomberg | Getty Images The Food and Drug Administration has refused to start a review of Moderna‘s application for its experimental flu shot, the company announced Tuesday, in another sign of the […]

Read More
Estee Lauder sues Walmart alleging ‘despicable’ sale of counterfeit beauty products
Business

Estee Lauder sues Walmart alleging ‘despicable’ sale of counterfeit beauty products

Walmart Inc. signage during the company’s listing at the Nasdaq MarketSite in New York, US, on Tuesday, Dec. 9, 2025. Michael Nagle | Bloomberg | Getty Images Estee Lauder sued Walmart in California federal court over allegations the big-box retailer sold counterfeit beauty products on its website and didn’t do enough to ensure only authorized […]

Read More
How this French building behemoth wants to solve the U.S. housing dilemma
Business

How this French building behemoth wants to solve the U.S. housing dilemma

A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight to your inbox. French […]

Read More